Scientists at the University of East Anglia (UEA) found that combining the RA therapy leflunomide with the melanoma treatment selumetinib almost completely stopped the growth of a melanoma tumour in mice. Selumetinib targets the activity […]
Manufactured from the patient’s own blood, CellProtect is said to be the first drug candidate consisting of autologous ex-vivo activated and expanded natural killer (NK) cells. The company has performed a clinical phase I/II trial […]
HPV is a well-known cause of cervical cancer and genital warts in women but the public is much less aware of its potential impact on men. According to the Royal Society for Public Health, just […]
As the U.S. enters a potentially rough influenza season, health experts are presenting new vaccination guidelines saying there’s no safety difference for flu shots given to people with egg allergies and those without. Historically, healthcare […]
Top-line results from the Phase III trial show that the primary efficacy objective was met for both cariprazine 1.5mg and 3mg formulations, with showing a significantly greater improvement than placebo for the change from baseline […]